Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Rectal Neoplasms × Aspirin × Clear all

Phase

Status

Unknown 2 Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 3 Adenoma 2 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Thrombocytopenia 1 Soft Tissue Neoplasms 1 Rectal Neoplasms 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myocardial Infarction 1 Multiple Myeloma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematuria 1 Hematologic Diseases 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Adenomatous Polyps 1 Adenocarcinoma of Lung 1 Acute Coronary Syndrome 1

Interventions

Capecitabine 31 Oxaliplatin 29 Fluorouracil 27 Leucovorin 24 Irinotecan 21 Bevacizumab 18 Radiotherapy 14 Cetuximab 14 Radiation 8 Surgical Procedures, Operative 6 Radiotherapy, Intensity-Modulated 5 Chemotherapy, Adjuvant 5 Neoadjuvant Therapy 4 Immunohistochemistry 4 Gene Expression Profiling 4 cediranib 3 Folfox protocol 3 Celecoxib 3 Biopsy 3 Amplified Fragment Length Polymorphism Analysis 3 regorafenib 2 Surveys and Questionnaires 2 Reverse Transcriptase Polymerase Chain Reaction 2 Receptor Protein-Tyrosine Kinases 2 Proctectomy 2 Polymerase Chain Reaction 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Gefitinib 2 Floxuridine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03170115 2020-12-17

ICAR

Instituto Nacional de Cancer, Brazil

Phase 2 Terminated

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡